Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials

BACKGROUND: Vonoprazan is a new potassium‐competitive acid blocker for treatment of acid‐related diseases. AIM: To conduct two randomised‐controlled trials, to evaluate the non‐inferiority of vonoprazan vs. lansoprazole, a proton pump inhibitor, for treatment of gastric ulcer (GU) or duodenal ulcer...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Aliment Pharmacol Ther
Hlavní autoři: Miwa, H., Uedo, N., Watari, J., Mori, Y., Sakurai, Y., Takanami, Y., Nishimura, A., Tatsumi, T., Sakaki, N.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Randomised Clinical Trial
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6680291/
https://ncbi.nlm.nih.gov/pubmed/27891632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13876
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky